HALO•benzinga•
Piper Sandler Maintains Neutral on Halozyme Therapeutics, Raises Price Target to $53
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on January 10, 2025 by benzinga